Related references
Note: Only part of the references are listed.Trends in Antidiabetic Drug Discovery: FDA Approved Drugs, New Drugs in Clinical Trials and Global Sales
Amelia D. Dahlen et al.
FRONTIERS IN PHARMACOLOGY (2022)
Repositioning of antidiabetic drugs for Alzheimer's disease: possibility of Wnt signaling modulation by targeting LRP6 an in silico based study
Suman Manandhar et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)
Dietary sugar intake and risk of Alzheimer's disease in older women
Longjian Liu et al.
NUTRITIONAL NEUROSCIENCE (2022)
Caspase-cleaved tau is senescence-associated and induces a toxic gain of function by putting a brake on axonal transport
Christian Conze et al.
MOLECULAR PSYCHIATRY (2022)
The role of glucose in cognition, risk of dementia, and related biomarkers in individuals without type 2 diabetes mellitus or the metabolic syndrome: A systematic review of observational studies
Mariam Kirvalidze et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2022)
Inhibition of Insulin Degrading Enzyme to Control Diabetes Mellitus and its Applications on some Other Chronic Disease: a Critical Review
Md. Shofiul Azam et al.
PHARMACEUTICAL RESEARCH (2022)
The impact of diabetes on cognitive impairment and its progression to dementia
Abigail Dove et al.
ALZHEIMERS & DEMENTIA (2021)
Tau aggregation and its relation to selected forms of neuronal cell death
Aviva M. Tolkovsky et al.
MOLECULAR MECHANISMS OF NEURODEGENERATION (2021)
Oral administration of mangiferin ameliorates diabetes in animal models: a meta-analysis and systematic review
You Wu et al.
NUTRITION RESEARCH (2021)
Tau Post-translational Modifications: Dynamic Transformers of Tau Function, Degradation, and Aggregation
Carolina Alquezar et al.
FRONTIERS IN NEUROLOGY (2021)
Association of metformin use with Alzheimer's disease in patients with newly diagnosed type 2 diabetes: a population-based nested case-control study
Junghee Ha et al.
SCIENTIFIC REPORTS (2021)
Insulin-Like Growth Factor-1 Differentially Modulates Glutamate-Induced Toxicity and Stress in Cells of the Neurogliovascular Unit
Cellas A. Hayes et al.
FRONTIERS IN AGING NEUROSCIENCE (2021)
The role of pathological tau in synaptic dysfunction in Alzheimer's diseases
Moxin Wu et al.
TRANSLATIONAL NEURODEGENERATION (2021)
Association Between Age at Diabetes Onset and Subsequent Risk of Dementia
Claudio Barbiellini Amidei et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Brain Glucose Metabolism in Health, Obesity, and Cognitive Decline-Does Insulin Have Anything to Do with It? A Narrative Review
Eleni Rebelos et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Insulin Resistance and Diabetes Mellitus in Alzheimer's Disease
Jesus Burillo et al.
CELLS (2021)
Differential effects of risk factors on the cognitive trajectory of early- and late-onset Alzheimer's disease
Jaeho Kim et al.
ALZHEIMERS RESEARCH & THERAPY (2021)
Cholesterol and Alzheimer's Disease; From Risk Genes to Pathological Effects
Femke M. Feringa et al.
FRONTIERS IN AGING NEUROSCIENCE (2021)
Possible Mechanisms of Tau Spread and Toxicity in Alzheimer's Disease
Huiqin Zhang et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Association of Alzheimer's Disease and Insulin Resistance in King Abdulaziz Medical City, Jeddah
Norah T. Faqih et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2021)
Interaction between Aβ and Tau in the Pathogenesis of Alzheimer's Disease
Huiqin Zhang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)
Type 2 Diabetes Interacts With Alzheimer Disease Risk Factors to Predict Functional Decline
Kelsey R. Thomas et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2020)
Metabolism: A Novel Shared Link between Diabetes Mellitus and Alzheimer's Disease
Yanan Sun et al.
JOURNAL OF DIABETES RESEARCH (2020)
Neurodegenerative Diseases - Is Metabolic Deficiency the Root Cause?
Vignayanandam Ravindernath Muddapu et al.
FRONTIERS IN NEUROSCIENCE (2020)
Impact of antidiabetic agents on dementia risk: A Bayesian network meta-analysis
Jian-Bo Zhou et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2020)
Effect of Acupuncture on the p38 Signaling Pathway in Several Nervous System Diseases: A Systematic Review
Tzu-Hsuan Wei et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Involvement of p38 MAPK in Synaptic Function and Dysfunction
Chiara Falcicchia et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Glucose transporters in brain in health and disease
Hermann Koepsell
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2020)
Pathological Mechanisms Linking Diabetes Mellitus and Alzheimer's Disease: the Receptor for Advanced Glycation End Products (RAGE)
Yanyan Kong et al.
FRONTIERS IN AGING NEUROSCIENCE (2020)
Antidiabetic Drugs for the Risk of Alzheimer Disease in Patients With Type 2 DM Using FAERS
Hayato Akimoto et al.
AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS (2020)
APOE4 is associated with cognitive and pathological heterogeneity in patients with Alzheimer's disease: a systematic review
Sheina Emrani et al.
ALZHEIMERS RESEARCH & THERAPY (2020)
Adult hippocampal neurogenesis is abundant in neurologically healthy subjects and drops sharply in patients with Alzheimer's disease
Elena P. Moreno-Jimenez et al.
NATURE MEDICINE (2019)
The Link Between Tau and Insulin Signaling: Implications for Alzheimer's Disease and Other Tauopathies
Rafaella Araujo Goncalves et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2019)
Amyloid β Induces Early Changes in the Ribosomal Machinery, Cytoskeletal Organization and Oxidative Phosphorylation in Retinal Photoreceptor Cells
Liting Deng et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)
Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer's disease
Ramsey Najm et al.
MOLECULAR NEURODEGENERATION (2019)
Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies
Yu Yamazaki et al.
NATURE REVIEWS NEUROLOGY (2019)
Type-2-Diabetes Alters CSF but Not Plasma Metabolomic and AD Risk Profiles in Vervet Monkeys
Kylie Kavanagh et al.
FRONTIERS IN NEUROSCIENCE (2019)
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
Justin M. Long et al.
CELL (2019)
In vitro and in vivo evidence that quercetin protects against diabetes and its complications: A systematic review of the literature
Guang-Jiang Shi et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Alzheimer's disease: risk factors and potentially protective measures
Marcos Vinicius Ferreira Silva et al.
JOURNAL OF BIOMEDICAL SCIENCE (2019)
Diabetes mellitus and Alzheimer's disease: GSK-3β as a potential link
Ying Zhang et al.
BEHAVIOURAL BRAIN RESEARCH (2018)
A new entry into the portfolio of α-glucosidase inhibitors as potent therapeutics for type 2 diabetes: Design, bioevaluation and one-pot multi-component synthesis of diamine-bridged coumarinyl oxadiazole conjugates
Madiha Kazmi et al.
BIOORGANIC CHEMISTRY (2018)
Human Hippocampal Neurogenesis Persists throughout Aging
Maura Boldrini et al.
CELL STEM CELL (2018)
Action of Phytochemicals on Insulin Signaling Pathways Accelerating Glucose Transporter (GLUT4) Protein Translocation
Abu Sadat Md Sayem et al.
MOLECULES (2018)
Insulin-signaling Pathway Regulates the Degradation of Amyloid β-protein via Astrocytes
Naoki Yamamoto et al.
NEUROSCIENCE (2018)
A comprehensive review on xanthone derivatives as α-glucosidase inhibitors
Clementina M. M. Santos et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Type 2 Diabetes Mellitus and Alzheimer's Disease: Role of Insulin Signalling and Therapeutic Implications
Andrea Tumminia et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Mechanism involved in insulin resistance via accumulation of beta-amyloid and neurofibrillary tangles: link between type 2 diabetes and Alzheimer's disease
Sima Kianpour Rad et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
Calpain-mediated tau fragmentation is altered in Alzheimer's disease progression
Hsu-Hsin Chen et al.
SCIENTIFIC REPORTS (2018)
Meta-analysis and critical review on the efficacy and safety of alpha-glucosidase inhibitors in Asian and non-Asian populations
Xueying Gao et al.
JOURNAL OF DIABETES INVESTIGATION (2018)
Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer's disease Neurons
Ravi Rajmohan et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
alpha-Glucosidase inhibition by flavonoids: an in vitro and in silico structure-activity relationship study
Carina Proenca et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2017)
High glucose induces formation of tau hyperphosphorylation via Cav-1-mTOR pathway: A potential molecular mechanism for diabetes-induced cognitive dysfunction
Jing Wu et al.
ONCOTARGET (2017)
Insulin Resistance as a Link between Amyloid-Beta and Tau Pathologies in Alzheimer's Disease
Roger J. Mullins et al.
FRONTIERS IN AGING NEUROSCIENCE (2017)
ApoE isoforms differentially regulates cleavage and secretion of BDNF
Abhik Sen et al.
MOLECULAR BRAIN (2017)
In Vitro Screening of Three Indian Medicinal Plants for Their Phytochemicals, Anticholinesterase, Antiglucosidase, Antioxidant, and Neuroprotective Effects
Mohan Penumala et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Resveratrol induces dephosphorylation of Tau by interfering with the MID1-PP2A complex
Susann Schweiger et al.
SCIENTIFIC REPORTS (2017)
Tau hyperphosphorylation induces oligomeric insulin accumulation and insulin resistance in neurons
Patricia Rodriguez-Rodriguez et al.
BRAIN (2017)
Is Alzheimer's disease a Type 3 Diabetes? A critical appraisal
Ramesh Kandimalla et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2017)
Efficacy of acarbose and metformin in newly diagnosed type 2 diabetes patients stratified by HbA1c levels
Jin-Ping Zhang et al.
JOURNAL OF DIABETES (2016)
Brain Insulin Signaling Is Increased in Insulin-Resistant States and Decreases in FOXOs and PGC-1α and Increases in Aβ1-40/42 and Phospho-Tau May Abet Alzheimer Development
Mini Sajan et al.
DIABETES (2016)
Human Truncated Tau Induces Mature Neurofibrillary Pathology in a Mouse Model of Human Tauopathy
Ivana Zimova et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Changes in insulin and insulin signaling in Alzheimer's disease: cause or consequence?
Molly Stanley et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
The Effects of Peripheral and Central High Insulin on Brain Insulin Signaling and Amyloid-β in Young and Old APP/PS1 Mice
Molly Stanley et al.
JOURNAL OF NEUROSCIENCE (2016)
OBESITY, DIABETES, AND LEPTIN RESISTANCE PROMOTE TAU PATHOLOGY IN A MOUSE MODEL OF DISEASE
T. L. Platt et al.
NEUROSCIENCE (2016)
Effects of Glucose and Insulin on Secretion of Amyloid-β by Human Adipose Tissue Cells
William G. Tharp et al.
OBESITY (2016)
Chronic hyperglycemia induced via the heterozygous knockout of Pdx1 worsens neuropathological lesion in an Alzheimer mouse model
Chuang Guo et al.
SCIENTIFIC REPORTS (2016)
Abnormal tau induces cognitive impairment through two different mechanisms: synaptic dysfunction and neuronal loss
J. Di et al.
SCIENTIFIC REPORTS (2016)
Saffron with resistance exercise improves diabetic parameters through the GLUT4/AMPK pathway in-vitro and in-vivo
Firouzeh Dehghan et al.
SCIENTIFIC REPORTS (2016)
Alteration in amyloid β42, phosphorylated tau protein, interleukin 6, and acetylcholine during diabetes-accelerated memory dysfunction in diabetic rats: correlation of amyloid β42 with changes in glucose metabolism
You Zhou et al.
BEHAVIORAL AND BRAIN FUNCTIONS (2015)
Long-term acarbose administration alleviating the impairment of spatial learning and memory in the SAMP8 mice was associated with alleviated reduction of insulin system and acetylated H4K8
Wen-Wen Yan et al.
BRAIN RESEARCH (2015)
Hyperglycemia modulates extracellular amyloid-β concentrations and neuronal activity in vivo
Shannon L. Macauley et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Neuroinflammation in Alzheimer's disease
Michael T. Heneka et al.
LANCET NEUROLOGY (2015)
The Possible Mechanism of Advanced Glycation End Products (AGEs) for Alzheimer's Disease
Shun-Yao Ko et al.
PLOS ONE (2015)
Insulin Resistance is Associated with Higher Cerebrospinal Fluid Tau Levels in Asymptomatic APOE ε4 Carriers
Erika J. Starks et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Insulin therapy modulates mitochondrial dynamics and biogenesis, autophagy and tau protein phosphorylation in the brain of type 1 diabetic rats
R. X. Santos et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
APOE associations with severe CAA-associated vasculopathic changes: collaborative meta-analysis
Kristiina Rannikmaee et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)
Single-molecule tracking of tau reveals fast kiss-and-hop interaction with microtubules in living neurons
Dennis Janning et al.
MOLECULAR BIOLOGY OF THE CELL (2014)
Impaired glycemia increases disease progression in mild cognitive impairment
Jill K. Morris et al.
NEUROBIOLOGY OF AGING (2014)
ApoE and Aβ in Alzheimer's Disease: Accidental Encounters or Partners?
Takahisa Kanekiyo et al.
NEURON (2014)
mTOR-mediated hyperphosphorylation of tau in the hippocampus is involved in cognitive deficits in streptozotocin-induced diabetic mice
Shan Wang et al.
METABOLIC BRAIN DISEASE (2014)
Diabetes Mellitus and the Risk of Alzheimer's Disease: A Nationwide Population-Based Study
Chin-Chou Huang et al.
PLOS ONE (2014)
Glycogen Synthase Kinase-3 Regulates Production of Amyloid-β Peptides and Tau Phosphorylation in Diabetic Rat Brain
Zhong-Sen Qu et al.
SCIENTIFIC WORLD JOURNAL (2014)
Insulin dysfunction and Tau pathology
Noura B. El Khoury et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
Brain Aging and AD-Like Pathology in Streptozotocin-Induced Diabetic Rats
Jian-Qin Wang et al.
JOURNAL OF DIABETES RESEARCH (2014)
Dynamics of Hippocampal Neurogenesis in Adult Humans
Kirsty L. Spalding et al.
CELL (2013)
Deregulation of Protein Phosphatase 2A and Hyperphosphorylation of τ Protein Following Onset of Diabetes in NOD Mice
Marie-Amelie Papon et al.
DIABETES (2013)
Age-dependent increases in tau phosphorylation in the brains of type 2 diabetic rats correlate with a reduced expression of p62
Hyun-Jung Jung et al.
EXPERIMENTAL NEUROLOGY (2013)
Hyperglycemia-Induced Tau Cleavage in vitro and in vivo: A Possible Link Between Diabetes and Alzheimer's Disease
Bhumsoo Kim et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Neuron Enriched Nuclear Proteome Isolated from Human Brain
Eric B. Dammer et al.
JOURNAL OF PROTEOME RESEARCH (2013)
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Chia-Chan Liu et al.
NATURE REVIEWS NEUROLOGY (2013)
Glucose Levels and Risk of Dementia
Paul K. Crane et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
High Glucose Promotes Aβ Production by Inhibiting APP Degradation
Yi Yang et al.
PLOS ONE (2013)
Comparisons of the Efficacy of Alpha Glucosidase Inhibitors on Type 2 Diabetes Patients between Asian and Caucasian
Xiaoling Cai et al.
PLOS ONE (2013)
Diabetes exacerbates amyloid and neurovascular pathology in aging-accelerated mice
Antonio Currais et al.
AGING CELL (2012)
Central Obesity in the Elderly is Related to Late-onset Alzheimer Disease
Jose A. Luchsinger et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2012)
Plasma Signaling Proteins in Persons at Genetic Risk for Alzheimer Disease Influence of APOE Genotype
John M. Ringman et al.
ARCHIVES OF NEUROLOGY (2012)
Amyloid-β Induces Hepatic Insulin Resistance by Activating JAK2/STAT3/SOCS-1 Signaling Pathway
Yi Zhang et al.
DIABETES (2012)
Apolipoprotein E3 (ApoE3) but Not ApoE4 Protects against Synaptic Loss through Increased Expression of Protein Kinase Cε
Abhik Sen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Apolipoprotein E controls cerebrovascular integrity via cyclophilin A
Robert D. Bell et al.
NATURE (2012)
Apolipoprotein E Sets the Stage: Response to Injury Triggers Neuropathology
Robert W. Mahley et al.
NEURON (2012)
Mechanisms Underlying Insulin Deficiency-Induced Acceleration of β-Amyloidosis in a Mouse Model of Alzheimer's Disease
Latha Devi et al.
PLOS ONE (2012)
Apolipoprotein E isoforms and regulation of the innate immune response in brain of patients with Alzheimer's disease
C. Dirk Keene et al.
CURRENT OPINION IN NEUROBIOLOGY (2011)
ApoE is required for maintenance of the dentate gyrus neural progenitor pool
Cui-Ping Yang et al.
DEVELOPMENT (2011)
Hyperphosphorylated truncated protein tau induces caspase-3 independent apoptosis-like pathway in the Alzheimer's Disease cellular model
Monika Zilkova et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Truncation of tau at E391 Promotes Early Pathologic Changes in Transgenic Mice
Pamela J. McMillan et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2011)
Adult hippocampal neurogenesis and its role in Alzheimer's disease
Yangling Mu et al.
MOLECULAR NEURODEGENERATION (2011)
Post-translational modifications of tau protein: Implications for Alzheimer's disease
Ludovic Martin et al.
NEUROCHEMISTRY INTERNATIONAL (2011)
Implicating Calpain in Tau-Mediated Toxicity In Vivo
James B. Reinecke et al.
PLOS ONE (2011)
Variants at APOE Influence Risk of Deep and Lobar Intracerebral Hemorrhage
Alessandro Biffi et al.
ANNALS OF NEUROLOGY (2010)
Type 1 diabetes exaggerates features of Alzheimer's disease in APP transgenic mice
Corinne G. Jolivalt et al.
EXPERIMENTAL NEUROLOGY (2010)
Phosphorylation of Tau at Thr212, Thr231, and Ser262 Combined Causes Neurodegeneration
Alejandra D. Alonso et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Apolipoprotein E4 Causes Age- and Tau-Dependent Impairment of GABAergic Interneurons, Leading to Learning and Memory Deficits in Mice
Yaisa Andrews-Zwilling et al.
JOURNAL OF NEUROSCIENCE (2010)
Insulin resistance is associated with the pathology of Alzheimer disease The Hisayama Study
T. Matsuzaki et al.
NEUROLOGY (2010)
PROGRESSIVE LOSS OF SYNAPTIC INTEGRITY IN HUMAN APOLIPOPROTEIN E4 TARGETED REPLACEMENT MICE AND ATTENUATION BY APOLIPOPROTEIN E2
R. C. Klein et al.
NEUROSCIENCE (2010)
Linking type 2 diabetes and Alzheimer's disease
Weiping Han et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
ApoE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recycling
Ying Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Apolipoprotein E-Dependent Accumulation of Alzheimer Disease-Related Lesions Begins in Middle Age
Eloise Kok et al.
ANNALS OF NEUROLOGY (2009)
Roles of the lipid peroxidation product 4-hydroxynonenal in obesity, the metabolic syndrome, and associated vascular and neurodegenerative disorders
Mark P. Mattson
EXPERIMENTAL GERONTOLOGY (2009)
ApoE4 Decreases Spine Density and Dendritic Complexity in Cortical Neurons In Vivo
Sonya B. Dumanis et al.
JOURNAL OF NEUROSCIENCE (2009)
Characterizing the Appearance and Growth of Amyloid Plaques in APP/PS1 Mice
Ping Yan et al.
JOURNAL OF NEUROSCIENCE (2009)
Identification of a caspase-derived N-terminal tau fragment in cellular and animal Alzheimer's disease models
V. Corsetti et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2008)
Insulin dysfunction induces in vivo tau hyperphosphorylation through distinct mechanisms
Emmanuel Planel et al.
JOURNAL OF NEUROSCIENCE (2007)
Soluble Aβ inhibits specific signal transduction cascades common to the insulin receptor pathway
Matthew Townsend et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Alzheimer-like changes in rat models of spontaneous diabetes
Zhen-guo Li et al.
DIABETES (2007)
Stepwise proteolysis liberates tau fragments that nucleate the Alzheimer-like aggregation of full-length tau in a neuronal cell model
Y. P. Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Neurodegeneration caused by expression of human truncated tau leads to progressive neurobehavioural impairment in transgenic rats
Miroslaua Hrnkova et al.
BRAIN RESEARCH (2007)
Low-dose acarbose does not delay digestion of starch but reduces its bioavailability
R. E. Wachters-Hagedoorn et al.
DIABETIC MEDICINE (2007)
The effect of borderline diabetes on the risk of dementia and Alzheimer's disease
Weili Xu et al.
DIABETES (2007)
Tau is hyperphosphorylated at multiple sites in mouse brain in vivo after streptozotocin-induced insulin deficiency
Buffie J. Clodfelder-Miller et al.
DIABETES (2006)
Effects of sodium ferulate on amyloid-beta-induced MKK3/MKK6-p38 MAPK-Hsp27 signal pathway and apoptosis in rat hippocampus
Ying Jin et al.
ACTA PHARMACOLOGICA SINICA (2006)
Truncated tau from sporadic Alzheimer's disease suffices to drive neurofibrillary degeneration in vivo
Norbert Zilka et al.
FEBS LETTERS (2006)
C-terminal truncation modulates both nucleation and extension phases of τ fibrillization
HS Yin et al.
FEBS LETTERS (2006)
Synaptic activity regulates interstitial fluid amyloid-β levels in vivo
JR Cirrito et al.
NEURON (2005)
The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer's disease
E Carro et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
APOE genotype and an ApoE-mimetic peptide modify the systemic and central nervous system inflammatory response
JR Lynch et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Alzheimer's missing link?
[Anonymous]
MOLECULAR THERAPY (2003)
Caspase cleavage of tau: Linking amyloid and neurofibrillary tangles in Alzheimer's disease
TC Gamblin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Insulin receptor substrate-2 deficiency impairs brain growth and promotes tau phosphorylation
M Schubert et al.
JOURNAL OF NEUROSCIENCE (2003)
Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo
W Farris et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Effect of amyloid precursor protein 17mer peptide on microtubule structure and tau protein hyperphosphorylation in hippocampal neurons of experimental diabetic mice
YM Zhao et al.
NEUROREPORT (2003)
Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer's disease patients
Y Ji et al.
NEUROSCIENCE (2003)
Apolipoprotein E and apolipoprotein E receptors modulate Aβ-induced glial neuroinflammatory responses
MJ LaDu et al.
NEUROCHEMISTRY INTERNATIONAL (2001)
Stimulation of β-amyloid precursor protein trafficking by insulin reduces intraneuronal β-amyloid and requires mitogen-activated protein kinase signaling
L Gasparini et al.
JOURNAL OF NEUROSCIENCE (2001)